Amgen Inc., the world’s largest
biotechnology company by sales, in
an attempt to close the deal in it’s
pursuit of Onyx Pharmaceuticals
has increased its offer to $130 per
share after a $120 offer was rejected
according to Bloomberg.
AstraZeneca, Pfizer, Bayer AG,
Bristol-Myers Squibb and Novartis
are also believed to be preparing
offers for the company which makes
cancer therapy Nexavar.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 13
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.